International Study Confirms Significant, Sustained IOP and Medication Reduction Following Standalone Implantation of Glaukos’ iStent inject® in Glaucoma Patients with Substantial Disease Burden
iStent inject Achieved 42% Reduction in Mean IOP to 14.6 mmHg and 82% Reduction in Mean Medications to 0.55 at...